<DOC>
	<DOCNO>NCT02806232</DOCNO>
	<brief_summary>The Phase II study consist two part , part 1 open label , randomize , control exploratory dose find child age 2 6 year infect S. mansoni . Part 2a investigates efficacy safety child 3 month 2 year age-de-escalating design part 2b optional investigates efficacy L-PZQ S. hematobium .</brief_summary>
	<brief_title>An Open Label Dose Finding Safety Efficacy Children Infants Infected With Schistosomiasis ( S.Mansoni )</brief_title>
	<detailed_description />
	<mesh_term>Schistosomiasis</mesh_term>
	<mesh_term>Praziquantel</mesh_term>
	<criteria>Male female child age 2 6 year ( Part 1 2b ) 3 24 month ( Part 2a ) S. mansoni positive diagnosis Part 1 Part 2a , define positive egg count stool ( great [ &gt; ] 1 egg/1 occasion ) accord World Health Organization ( WHO ) classification : light ( 199 egg per gram faeces ) , moderate ( 100399 egg per gram faeces ) heavy ( great equal [ &gt; = ] 400 egg per gram faeces ) infection S. haematobium positive diagnosis Part 2b , define positive egg count urine ( &gt; 2 eggs/10 milliliter [ ml ] urine ) accord WHO classification : light ( less [ &lt; ] 50 eggs/10 ml urine ) heavy ( &gt; =50 eggs/10 ml urine ) infection Minimum weight 8.0 kg 2 6yearold child 4.0 kg 3 24month infant â€¢ Parents/legal guardian 's ability communicate well Investigator , understand protocol requirement restriction , willing child comply requirement entire trial , i.e . To examine study physician screening 1421 day treatment To provide stool urine sample screen , 24 hour 8 day treatment , well 1421 day treatment To provide finger prick blood sample Pharmacokinetics ( PK ) study blood sample safety assessment Treatment 4 week prior study screen Praziquantel ( PZQ ) , antihelminthic , antimalarial antiretroviral compound medication might affect PK PZQ certain antiepileptic ( e.g. , carbamazepine phenytoin ) , glucocorticosteroids ( e.g. , dexamethasone ) , chloroquine , rifampicin cimetidine For child breast fed , treatment mothers/wet nurse PZQ 3 day prior administration Investigational medicinal product Previous history adverse reaction associate PZQ treatment History acute severe chronic disease include hepatosplenic schistosomiasis Fever define temperature 38.0 degree centigrade Debilitating illnesses tuberculosis , malnutrition , etc . Mixed S. haematobium S. mansoni infection Findings clinical examination schistosomeinfected child participate study perform study clinician treatment day , opinion Investigator constitute risk contraindication participation subject study could interfere study objective , conduct evaluation Unlikelihood comply protocol requirement , instruction trialrelated restriction , e.g. , uncooperative attitude , inability return followup visit , improbability complete trial</criteria>
	<gender>All</gender>
	<minimum_age>3 Months</minimum_age>
	<maximum_age>6 Years</maximum_age>
	<verification_date>January 2017</verification_date>
	<keyword>Praziquantel ODT formulation</keyword>
	<keyword>Biltricide</keyword>
</DOC>